CryptoCISO

diverseoptiontrades: CryptoCISO Forensic Risk Assessment

CryptoCISO Risk Verdict
Severe Risk · Score 89/100
Forensic assessment of diverseoptiontrades by the CryptoCISO blockchain intelligence team.

Threat Profile

Operating from an unverified domain, diverseoptiontrades advertises high-return crypto and CFD trading to the public. CryptoCISO flagged the operator during routine counterparty-risk screening.

Regulatory Posture

On the regulatory side, diverseoptiontrades does not hold a verifiable financial-services licence. Its only apparent footprint is a corporate registration in United Kingdom – a jurisdiction whose company registry confers International Business Company status, not authorisation to handle client funds or operate a brokerage. An IBC filing is a corporate formality, not financial oversight.

Indicators We Flagged

  • No verifiable licence from a top-tier financial regulator
  • Incorporation in United Kingdom presented as if it were regulation
  • Offshore or shell-company structure used to obscure ownership
  • Opaque corporate identity and unverifiable team or address
  • Aggressive or unsolicited outreach and pressure to deposit quickly

On-Chain & Operational Notes

Where we have visibility, funds sent to comparable operators move rapidly off-platform into obfuscation infrastructure. The window for effective blockchain tracing is widest immediately after the transfer, which is why prompt documentation matters.

CryptoCISO Risk Verdict

On balance, diverseoptiontrades carries a severe risk profile. The evidence points away from a legitimate, supervised brokerage and toward an operation structured to retain deposits.

If Your Funds Are Exposed

Should you be exposed, halt further payments and ignore demands for upfront fees to ‘free’ your balance. Gather your evidence – TXIDs, wallet addresses, screenshots, and correspondence – while it is still accessible. Early, organised evidence is what makes downstream tracing and reporting viable.

Request a confidential CryptoCISO assessment →